NCT03300492 Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS Status RECRUITING Phase PHASE1/PHASE2
NCT03291444 CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS Status RECRUITING Phase PHASE1
NCT03286114 Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab Status TERMINATED Phase PHASE1
NCT03258359 Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN) Status UNKNOWN Phase PHASE1
NCT03238248 Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors Status COMPLETED Phase PHASE2
NCT03233074 Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors Status TERMINATED Phase N/A
NCT03232268 HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies Status COMPLETED Phase PHASE1
NCT03223961 A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03187288 Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS Status COMPLETED Phase PHASE1
NCT03184935 Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS) Status SUSPENDED Phase PHASE1/PHASE2
NCT03176849 A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Status COMPLETED Phase PHASE4
NCT03176277 A Study of ONO-7475 in Patients With Acute Leukemias Status TERMINATED Phase PHASE1/PHASE2
NCT03175978 IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome Status TERMINATED Phase PHASE1/PHASE2
NCT03164057 A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03151304 A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes Status TERMINATED Phase PHASE2
NCT03140280 Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Status COMPLETED Phase PHASE2
NCT03138395 iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML Status WITHDRAWN Phase N/A